Last $7.76 USD
Change Today -0.34 / -4.20%
Volume 8.0K
CERU On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Oliver Steffen Fetzer Ph.D., MBA

AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 5 different industries.

See Board Relationships
50$685,056
As of Fiscal Year 2013

Background*

Dr. Oliver Steffen Fetzer, Ph.D., MBA, has been the Chief Executive Officer of Synthetic Genomics, Inc. since October 27, 2014. Dr. Fetzer has been Consultant of Cerulean Pharma Inc. since October 29, 2014. He served as the Chief Executive Officer and President of Cerulean Pharma Inc. from April 8, 2009 to October 29, 2014. Dr. Fetzer served as a Senior Vice President of Corporate Development and Research & Development at TerraGen Discovery, Inc. from July 2004 to September ...

Read Full Background

Corporate Headquarters*

840 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-551-9600
Fax: 617-494-1544

Board Members Memberships*

2005-2015
Former Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2009-2014
Consultant
2011-Present
Director, Chairman of Compensation Committee and Member of Nomination & Governance Committee
2014-Present
Chief Executive Officer and Director

Education*

MBA
Carnegie Mellon University
PhD
Medical University of South Carolina
BS
The College Of Charleston

Other Affiliations*

Annual Compensation*

Salary$352,000
Bonus$176,000
Total Annual Compensation$528,000

Stock Options*

All Other Compensation$10,968
Exercisable Options252,162
Unexercisable Options190,835
Total Number of Options442,997

Total Compensation*

Total Annual Cash Compensation$538,968
Total Short Term Compensation$528,000
Other Long Term Compensation$10,968
Total Calculated Compensation$685,056
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CERU:US $7.76 USD -0.34

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CERULEAN PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.